# A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

> **NCT05125354** · — · COMPLETED · sponsor: **Alpha Tau Medical LTD.** · enrollment: 33 (actual)

## Conditions studied

- Squamous Cell Carcinoma
- DaRT Treated Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05125354
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-06
- **Primary completion:** 2022-03-06
- **Final completion:** 2022-03-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05125354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05125354, "A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05125354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*